Poland· PL-100382145
Tivicay
A dolutegravir product containing dolutegravirum, registered in Poland by ViiV Healthcare BV. The same ATC class is registered in 13 of our 19 countries.
Checked against URPL (Poland) on
Informational only — not a medical device.
Where it is registered
Dolutegravir is registered in 13 of 19 countries.
Countries holding a registration under ATC J05AJ03 (dolutegravir), each read from that country’s own register.
- This record: Poland, from URPL (Poland)
- 8 of them publish a price we can compare per daily dose
Dolutegravir · ATC J05AJ03
13 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Icelandprice
- Ireland
- Netherlands
- Norwayprice
- Polandprice
- Switzerlandprice
- United Kingdom
- United Statesprice
Price per daily dose
What a daily dose of dolutegravir costs, country by country.
Normalised to the WHO defined daily dose (50 mg), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Dolutegravir · price per daily dose (50 mg)
USD · FX 28 Sept 2026
- CH Switzerland$25.85
The record
At a glance
URPL (Poland)- Active substance
- Dolutegravirum
- Manufacturer
- ViiV Healthcare BV
- Country
- Poland (PL)
- ATC code
- J05AJ03
- ATC class
- Dolutegravir
- Defined daily dose
- 50 mg, O
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909991309220
- gtin05909991309237
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
94 interactions on record for dolutegravir.
Graded by severity as the source publishes them — 42 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Dolutegravir · interactions on record
94 records
- 42 severe
- 3 moderate
- 49 minor
Most severe, free to view
- Magnesium carbonateA02AA01severe
- Magnesium oxideA02AA02severe
- Magnesium hydroxideA02AA04severe
- Kombinationen von AluminiumsalzenA02AB10severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Dolutegravir in 14 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United StatesTivicayViiV Healthcare Company
- CzechiaTIVICAYViiV Healthcare BV, Amersfoort
- FinlandTivicayViiV Healthcare BV
- FranceTIVICAY 10 mg, comprimé pelliculéVIIV HEALTHCARE (PAYS-BAS)
- BelgiumTivicay 10 mgViiV Healthcare
- IcelandTivicayViiV Healthcare BV
- NetherlandsTivicay 10 mg, filmomhulde tabletViiV healthcare B.V.
- SwedenTivicay 10 mg Filmdragerad tablettViiV Healthcare BV
Authorised across Europe · EMA
The same active substance is authorised in 5 EEA countries. Names it is sold under:
- Cyprus · Dogrivio
- Iceland · Tivicay
- Liechtenstein · Tivicay
- Norway · Dolutegravir Teva, Tivicay
- Sweden · Dogrivio, Dolutegravir Elpen
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/03e04557-2ff0-4499-aed1-967530c56fd0 GET /v1/drugs/03e04557-2ff0-4499-aed1-967530c56fd0?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tabletki powlekane",
"source": "urpl",
"strength": "10 mg",
"packaging": "05909991309220 ¦ Rpz ¦ EU/1/13/892/003 ¦ 119527\n1 butelka 30 tabl.\n05909991309237 ¦ Rpz ¦ EU/1/13/892/004 ¦ 119528\n1 butelka 90 tabl.",
"substance": "Dolutegravirum 10 mg",
"common_name": "Dolutegravirum",
"pl_product_id": "100382145",
"pozwolenie_nr": null,
"auth_procedure": "CEN",
"authorisation_validity": null
}See everything about dolutegravir.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.